The glycation of proteins by glucose has been linked to the development of diabetic complications and other diseases. Early glycation is thought to involve the reaction of glucose with Nterminal and lysyl side chain amino groups to form Schiff's base and fructosamine adducts. The formation of the α-oxoaldehydes, glyoxal, methylglyoxal and 3-deoxyglucosone, in early glycation was investigated. Glucose (50 mM) degraded slowly at pH 7n4 and 37 mC to form glyoxal, methylglyoxal and 3-deoxyglucosone throughout a 3-week incubation period. Addition of t-BOClysine and human serum albumin increased the rate of formation of α-oxoaldehydes -except glyoxal and methylglyoxal concentrations were low with albumin, as expected from the high reactivity of glyoxal and methylglyoxal with arginine residues. The degradation of fructosyl-lysine also formed glyoxal, methyl-
INTRODUCTION
Glycation, non-enzymatic glycosylation, is an endogenous process that contributes to the post-translational modification of proteins [1] . It is slow under physiological conditions, giving rise to the presence of lysine-and arginine-derived glycation adducts in cellular and extracellular proteins. Inside cells, the impact of glycation is countered by high turnover and short half-life of many cellular proteins. Long-lived extracellular proteins, however, accumulate glycation adducts with age [2, 3] . Some of these adducts may be removed by enzymatic repair mechanisms, whilst all are removed by degradation of the glycated protein. Degradation of extracellular glycated proteins requires specific recognition by receptors, internalization and proteolytic processing. There are specific receptors, AGE receptors, which fulfil this role [4] . Glycation of proteins has been linked to mechanisms of disease -particularly the development of chronic clinical complications associated with diabetes mellitus -retinopathy, neuropathy and nephropathy [5] , non-diabetic nephropathy [6] , macrovascular disease [7, 8] , Alzheimer's disease [9] , cataract [3] and ageing [2] .
Studies of protein glycation have focused on the reaction of aldoses and ketoses, particularly glucose, with lysine residues of proteins. The acyclic form of the monosaccharide reacts reversibly with the lysyl side chain amino group to form an initial Schiff's base adduct. This exists mainly in the cyclic glycosylamine form [10] . For human serum albumin (HSA) in blood plasma under physiological conditions, the equilibrium between glucose, HSA and the Schiff's base is established with a chemical relaxation time of about 2n5 h. The concentration of the Schiff's base at equilibrium is about 0n3 % of glucose concentration [11] . The acyclic form of the Schiff's base rearranges reversibly to form an N ε -(1-deoxy--fructos-1-yl) amino acid residue. This
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glyoxal and 3-deoxyglucosone. α-Oxoaldehyde formation was dependent on the concentration of phosphate buffer and availability of trace metal ions. This suggests that α-oxoaldehydes were formed in early glycation from the degradation of glucose and Schiff's base adduct. Since α-oxoaldehydes are important precursors of advanced glycation adducts, these adducts may be formed from early and advanced glycation processes. Short periods of hyperglycaemia, as occur in impaired glucose tolerance, may be sufficient to increase the concentrations of α-oxoaldehydes in i o.
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reaction is the Amadori rearrangement and the product is a fructosamine or ' Amadori product '. For HSA in blood plasma, the equilibrium dynamics of the Schiff's base and fructosamine are slower than of glucose and Schiff's base. From experimental data [12] , the estimated chemical relaxation time for fructosamine formation is about 38 h. The concentration of fructosamine in blood plasma of normal, healthy human subjects is about 140 µM, and increases 2-3-fold in diabetes mellitus [13] . This is the early glycation process and Schiff's base and fructosamines have been called collectively early glycation adducts [14] . Fructosamine degrades by reversal of the Amadori rearrangement to the Schiff's base, and by further oxidative and nonoxidative reactions to form many stable end-stage adducts, collectively called AGEs [15] . The reactions forming AGEs have been termed advanced glycation [14] . Some AGEs are nonsulphydryl crosslinks, such as pentosidine [16] and imidazolium derivatives [17, 18] , which confer abnormal stability of glycated proteins to mechanical forces and proteolytic degradation [19] . Some AGEs are also recognition factors for specific receptors of endothelial cells, monocytes, macrophages and other cells [20] . Agonist binding to AGE receptors is associated with cell activation -induction of adhesion molecule expression, cytokine and growth factor synthesis, and in some cases apoptosis [4] .
Recent research has shown that physiological glycation processes also involve the modification of proteins by reactive α-oxoaldehydes -particularly glyoxal, methylglyoxal and 3-deoxyglucosone (3-DG), and probably others. There appear to be AGE crosslinks and AGE receptor recognition factors common to proteins modified by glucose and α-oxoaldehydes. One explanation for this may be the formation of glyoxal, methylglyoxal and 3-DG during glycation of proteins by glucose, leading to associated α-oxoaldehydes-derived AGE formation.
In this report, we describe the formation of glyoxal, methyl-glyoxal and 3-DG from glucose degradation, and from lysyl residue and protein glycation by glucose in itro. They were formed from the earliest stages of glycation, suggesting that AGEs may be formed in early and advanced glycation. A mechanistic interpretation is given.
MATERIALS AND METHODS

Materials
Human serum albumin (fraction V ; HSA), nitroblue tetrazolium (NBT), N α -t-BOC--lysine, β--glucose and glyoxal were purchased from Sigma. Methylglyoxal, 3-DG, 1,2-diamino-4,5-dimethoxybenzene dihydrochoride (DDB) were prepared as described [21, 22] . 6,7-Dimethoxy-1-ethyl-2-methylquinoxaline (DEMQ) was prepared by reaction of DDB (0n2 mmol, 48n2 mg) and pentane-2,3-dione (0n4 mmol, 41n8 µl) in aqueous HCl (0n25 ml of 10n2 M HCl with 1n5 ml of water) under nitrogen for 6 h at room temperature. The product mixture was neutralized to pH 7 with 2 M potassium bicarbonate and the product crystallized. It was recrystallized from water : methanol (19 : 1, v\v N ε -(1-Deoxy--fructos-1-yl)lysine (fructosyl-lysine) was prepared by modification of published methods [12] . Briefly, N α -t-BOC-lysine (185 mg, 0n75 mmol), -glucose (1n65 g, 9n15 mmol) and methanol (31 ml) was refluxed for 4 h. The methanol was evaporated, the residue dissolved in 10 mM sodium phosphate buffer (pH 7n4, 2n5 ml) and applied to a solid-phase extraction cartridge (ODS, 500 mg, Waters-Millipore, Watford, U.K.), equilibrated with the same buffer. N α -t-BOC-N ε -(1-deoxy--fructos-1-yl)lysine (t-BOC-fructosamine) was eluted with the same buffer, located by analysing eluate fractions by TLC (silica gel 60 ; propan-1-ol, acetic acid, water 16 : 1 : 5 v\v\v) (locating agent ninhydrin 0n2 % in ethanol) and lyophilized. Crude t-BOCfructosamine was purified by preparative reversed phase HPLC (2n5 cmi10 cm ODS column) equilibrated with 50 mM acetic acid. The eluate absorbance was monitored at 230 nm, the flow rate was 9 ml\min with a linear gradient of 0-50 % methanol for 25 min. t-BOC-fructosamine was de-protected by stirring with 1 M HCl overnight at room temperature. The solution was lyophilized and fructosyl-lysine purified by similar preparative reversed phase HPLC with eluent of 50 mM acetic acid, 9n9 ml\min, and eluate absorbance monitored at 210 nm. The
), H-4 ; 3n96-4n00 2 H (m), H-5 and H-6B overlapping with lysyl α-CH. The mass spectrum (MALDI II) gave an (mj1)\z value of 309. TLC on silica gel 60 (mobile phase : propan-1-ol, acetic acid, water ; 16 : 1 : 5, v\v\v) gave an R f of 0n38. The product yields for each step were : t-BOCfructosamine 53 % and fructosyl-lysine 98 %.
Study of glyoxal, methylglyoxal and 3-DG formation in glucose degradation and glycation
The formation of glyoxal, methylglyoxal and 3-DG was studied in 100 mM sodium phosphate buffer, pH 7n4 and 37 mC over 3 weeks, under aseptic conditions, with incubations containing : (a) 50 mM glucose ; (b) 50 mM glucose and 50 mM N α -t-BOClysine ; (c) 50 mM glucose and 50 mg\ml HSA, and (d) 0n5 mM fructosyl-lysine. The effect of phosphate buffer concentration (10-100 mM) and chelation of trace metal ions with diethylenetriaminepenta-acetic acid (DETAPAC) was also investigated.
Assay of glyoxal, methylglyoxal and 3-DG
The concentrations of glyoxal, methylglyoxal and 3-DG were determined by derivatization with DDB and HPLC of the quinoxaline adducts. Several modifications have been made to the method since our first report [23] and other works. Since the avoidance of interferences was critical to this study, the procedure used herein is briefly described. Incubation sample (1 ml) and α-oxoaldehyde standards containing 0n05-5n00 nmol of 3-DG, glyoxal and methylglyoxal (1 ml, in incubation buffer) were placed into glass vials and acidified by addition of ice-cold perchloric acid (0n6 M, 1 ml) and kept on ice for 10 min. Where sample α-oxoaldehyde content exceeded 5 nmol, 0n05-0n50 ml of sample was analysed with addition of 0n95-0n50 ml of phosphate buffer. The internal standard, DEMQ, was added (20 µl of a 5 µM solution in 0n5 M HCl). Samples containing HSA were centrifuged (10 000 g, 5 min) at 4 mC. The supernatant was transferred into glass vials and the derivatizing agent, DDB (200 µl of a 1n11 mM solution in 0n5 M HCl, made immediately prior to addition) was added, and the samples were incubated at room temperature in the dark for 4 h. The pH of the samples was adjusted to 2n3 with Na # HPO % (0n5 M, about 1 ml). The samples were applied to solid phase extraction cartridges (ODS, 500 mg) equilibrated with 20 mM ammonium phosphate, pH 2n3, the cartridges were washed with the same buffer (2i2n8 ml) and the quinoxaline analytes eluted with methanol (2n8 ml). Methanol was removed at room temperature in acuo with a centrifugal evaporator, the residual solid reconstituted with 200 µl initial mobile phase (20 mM ammonium formate, pH 3n8, with 30 % methanol) and filtered (0n2 µm). Samples were analysed by HPLC : the column was 8 mmi10 cm NOVA-PAK ODS 4-µm cartridge in a radial compression unit. The flow rate was 2 ml\min with mobile phase of 20 mM ammonium formate, pH 3n8, and solvent programme : 0-40 isocratic 30 % methanol ; 40-75 min, a linear gradient of 30-60 % methanol. Detection was by fluorescence (λ excitation 352 nm, λ emission 385 nm). HPLC was performed with a Waters HPLC system (2i510 pumps, Lambda Max 481 LC spectrophotometer and 474 scanning fluorescence detector). For derivatized adducts of 3-DG, glyoxal and methylglyoxal : the retention times were 7n0, 17n3 and 24n0 min (retention time of the internal standard was 60n2 min) ; the recoveries 52, 70 and 59 % ; the limits of detection 21, 11 and 14 pmol ; and the interbatch coefficient of variation 15, 11 and 10 % (n l 9), respectively. There was no significant interference by glucose (50 mM) or fructosamine (1 mM) in the assay -except there was a small significant amount of 3-DG, 20 nM, detected in 50 mM glucose solution at zero time (this was attributed to a low contamination of glucose with 3-DG rather than degradation of glucose during the assay, since other degradation products of glucose were not present at zero time). Samples were stored at k196 mC for 6 weeks without significant loss of glyoxal, methylglyoxal or 3-DG.
Assay of fructosamine
Fructosamine content of incubations of glucose with N α -t-BOClysine and HSA were determined by the alkaline reduction of NBT using fructosyl-lysine as the calibration standard. α-Oxoaldehydes in glucose glycation
RESULTS
Glyoxal, methylglyoxal and 3-DG formation in the degradation of glucose under physiological conditions
When glucose (50 mM) was incubated for 3 weeks in 100 mM sodium phosphate buffer, pH 7n4 and 37 mC, glyoxal, methylglyoxal and 3-DG were formed (Figure 1 ). There were increases 
Scheme 1. Mechanistic interpretation of glyoxal, methylglyoxal, 3-deoxyglucosone and glucosone formation in glucose degradation
Unhydrated and acyclic forms of α-oxoaldehyde products are shown although glyoxal and methylglyoxal exist in solution mainly as monohydrates and dihydrates and 3-DG and glucosone as cyclic hemiacetal and hemiketal hydrates.
in the concentrations of all three α-oxoaldehydes over the incubation period. The final concentrations after 3 weeks were : glyoxal 59n5p3n7 µM, methylglyoxal 2n77p1n22 µM and 3-DG 7n46p1n48 µM (n l 3) (Figure 1a) . The initial rate of increase in α-oxoaldehyde concentration (determined over the initial 2 days) was : glyoxal 1n72p0n05 µM\day, methylglyoxal 0n098p0n003 µM\day and 3-DG 0n437p0n032 µM\day (n l 3). N α -t-BOC-lysine (a, c, e and g ) or 50 mg/ml HSA (b, d, f and h) in 100 mM sodium phosphate buffer, pH 7n4 and 37 mC, except e and f 10-100 mM sodium phosphate buffer, pH 7n4 and 37 mC. α-Oxoaldehydes in glucose glycation The initial rate of glyoxal formation was markedly dependent on the concentration of phosphate buffer and was markedly decreased in the presence of the metal ion chelator DETAPAC. The initial rates of formation of methylglyoxal and 3-DG were less dependent on phosphate buffer concentration and presence of DETAPAC (Figures 1b and 1c) .
A potential source of formation of methylglyoxal in glucose degradation and glycation reactions is from the fragmentation of 3-DG by a retroaldol condensation reaction (Scheme 1). To investigate this, 3-DG (50 µM) was incubated in 100 mM phosphate buffer, pH 7n4 and 37 mC, for 2 days. Methylglyoxal was indeed formed. Final α-oxoaldehyde concentrations were : 3-DG 43n1p2n4 µM, and methylglyoxal 0n09p0n03 µM (n l 3).
α-Oxoaldehyde and fructosamine formation in the glycation of N α -t-BOC-lysine and human serum albumin
Glycation of proteins by glucose initially occurs by interaction of glucose with N-terminal and lysyl side chain amino groups. To model this reaction, glucose (50 mM) was incubated with N α -t-BOC-lysine (50 mM) in 100 mM phosphate buffer, pH 7n4 and 37 mC. Glyoxal, 3-DG and methylglyoxal were formed. The concentrations of these α-oxoaldehydes increased rapidly in the initial 2-5 days ; thereafter, the concentrations remained at a maximum value and tended to slowly decrease at 21 days ( Figure  2a) . After 21 days, the α-oxoaldehyde concentrations were : glyoxal 43n7p4n0 µM, methylglyoxal 10n7p2n0 µM and 3-DG 14n8p0n5 µM. In contrast, the formation of fructosamine increased throughout the incubation period to 1424p8 µM after 21 days (Figure 2b ). The initial rates of α-oxoaldehyde formation were : glyoxal 8n09p0n78 µM\day, methylglyoxal 3n13p0n15 µM\day, 3-DG 2n62p0n62 µM\day. They were increased significantly with respect to glucose degradation (P 0n001). The initial rate of fructosamine formation (116p4 µM\day) was much higher than α-oxoaldehyde formation. The initial rates of α-oxoaldehyde formation were dependent on phosphate buffer concentration -particularly at phosphate concentration 50 mM, and decreased markedly in the presence of DETAPAC (Figures 2e and 2g) . In the presence of DETAPAC, the initial rates of glyoxal and 3-DG formation in the glycation of N α -t-BOC-lysine by glucose were not significantly different from those of glucose degradation (P 0n05). The initial rate of methylglyoxal formation in the glycation of N α -t-BOC-lysine by glucose was increased significantly, however, with respect to that of glucose degradation (P 0n01). A potential source of methylglyoxal formation in glucose glycation reactions is the fragmentation of 3-DG-N α -t-BOC-lysine aldimine Schiff's base adduct by a retroaldol condensation reaction. To investigate this, 3-DG (50 µM) was incubated in 100 mM phosphate buffer, pH 7n4 and 37 mC, in the presence of 50 mM N α -t-BOC-lysine for 2 days. Methylglyoxal was formed in this period. α-Oxoaldehyde concentrations were : 3-DG 30n3p2n0 µM and 0n55p0n08 µM (n l 3). Methylglyoxal formation was increased significantly by the presence of N α -t-BOC-lysine (P 0n001).
When a similar investigation was performed of 50 mM glucose incubated with HSA (50 mg\ml), there were also increases in the concentrations of 3-DG (Figure 2b ) and fructosamine ( Figure  2d ) with time. The concentrations of glyoxal and methylglyoxal, however, were very low ( 0n5 µM) throughout the incubation period (Figure 2b) . The initial rate of formation of 3-DG was dependent on phosphate buffer concentration and was decreased in the presence of DETAPAC but the initial rates of formation of glyoxal and methylglyoxal were not (Figure 2f and 2h) .
α-Oxoaldehyde formation in the degradation of fructosyl-lysine
Fructosyl-lysine (500 µM) degraded completely during the 21-day incubation period (Figure 3a) . This was associated with the formation of glyoxal, methylglyoxal and 3-DG. The concentrations of these α-oxoaldehydes increased rapidly in the initial 2-5 days, and thereafter approached maximum values (Figure 3b) . After 21 days, the α-oxoaldehyde concentrations were : glyoxal 34n1p3n5 µM, methylglyoxal 1n61p0n45 µM and 3-DG 8n80p2n86 µM. The initial rates of α-oxoaldehyde formation were : glyoxal 1n66p0n60 µM\day, methylglyoxal 0n55p0n01 µM\day, 3-DG 1n03p0n15 µM\day ; cf. the initial rate of fructosamine degradation which was 37n5p10n8 µM\day (n l 3). The initial rates of α-oxoaldehyde formation were dependent on phosphate buffer concentration, particularly for phosphate concentration 50 mM, and were markedly decreased in the presence of DETAPAC (Figures 3c and 3d) .
DISCUSSION
α-Oxoaldehyde formation in the degradation of glucose
Our initial study of glucose degradation in 1984 indicated that it was an oxidative process forming glucosone. We called this monosaccharide autoxidation [24] . From data presented herein and other reports [25, 26] , it can be seen that the spontaneous degradation of glucose under physiological conditions also forms glyoxal, methylglyoxal and 3-DG.
Glyoxal may be formed in the degradation of glucose by retroaldol condensation reactions activated by deprotonation of the 2-or 3-hydroxy groups. Concurrent oxidative processes forming hydrogen peroxide (autoxidation of glycoaldehyde to glyoxal, and glucose to glucosone) also stimulate glyoxal formation by hydroxyl radical-mediated acetal proton abstraction from glucopyranose and β-elimination reactions [24, 27] . 3-DG and glucosone formation occur by an initial common activation step, deprotonation of carbon-2 : re-distribution of the electron density between carbon-1 and carbon-2 leads to the formation of the ene-diol (enolization) [28] ; alternatively, re-distribution of the electron density between carbon-2 and carbon-3 leads to dehydration forming the 2,3-enol and thereby 3-DG. Methylglyoxal may be formed by fragmentation of 3-DG (Scheme 1). The initial rates of formation of glyoxal, methylglyoxal and 3-DG were dependent on phosphate buffer. This may be due to phosphate dianion HPO % #− catalysing the activating deprotonation of glucose [24] . The marked inhibition of glyoxal formation by DETAPAC is consistent with redox active metal ions (ferric Fe$ + and cupric Cu# + ) catalysing the autoxidation of glycoaldehyde and hydroxyl radical formation implicated in glyoxal formation [24] . The decrease of 3-DG formation by DETAPAC was unexpected but a similar effect has been observed previously in glucose glycation reactions [29] . Trace metal ionphosphate complexes may be involved in the activation of glucose for 3-DG formation.
α-Oxoaldehyde formation and early glycation of proteins by glucose
The formation of fructosamine residues is the major pathway of early glycation by glucose, but not the only one. In the model glycation of N α -t-BOC-lysine by glucose, the initial rate of formation of fructosamine was 8-fold higher than the initial rate of glyoxal, methylglyoxal and 3-DG formation combined (and about 16 % of this may be attributed to α-oxoaldehyde formation from glucose autoxidation). The formation of α-oxoaldehydes in early glycation, therefore, can be easily overlooked. α-Oxoaldehyde precursors of AGEs, such as 3-DG, and AGEs, were initially considered to be formed from fructosamine only. Recent research [30, 31] , mechanistic considerations [32] and this study suggest this is not so.
Glyoxal, methylglyoxal and 3-DG were formed in glucose glycation of N α -t-BOC-lysine early and throughout the incubation period. The change in α-oxoaldehyde concentration did not follow that of the fructosamine. α-Oxoaldehydes rather may be formed from other sources : from glucose degradation and from the Schiff's base. Mechanistically, we propose that α-oxoaldehyde formation occurs similarly to that envisaged in glucose degradation except for the presence of the aldimine moiety throughout ; the product is the aldimine Schiff's base of the α-oxoaldehyde (which hydrolyses to the free α-oxoaldehyde and amine) (Scheme 2). The presence of the aldimine group accelerates the formation of α-oxoaldehydes : the initial rates of formation of glyoxal, methylglyoxal and 3-DG were increased 5-fold, 32-fold and 6-fold, respectively, by the presence of N α -t-BOC-lysine, although there was only a significant increase in the rate of methylglyoxal formation in the presence of DETAPAC. The Amadori rearrangement is analogous to ene-diol formation in monosaccharide enolization : the ene-aminol moiety (NH-CH%COH) being isoelectronic with the ene-diol moiety (O-CH%COH). The formation of 3-DG and fructosamine are parallel reaction pathways from a common activating step. The critical point in the formation of both fructosamine and 3-DG is the deprotonation of carbon-2 of the Schiff's base. Fructosamine formation is facilitated by the polarizing effect of the imine bond of the Schiff's base that favours the ene-aminol formation. The formation of glyoxal from the Schiff's base was proposed by Namiki and co-workers [30] . Glyoxal formation may occur by retroaldol condensation or free radical mechanisms (see above). Indeed, superoxide radical formation from the Schiff's base in early glycation was detected [33] , supporting evidence for the involvement of oxidative processes in early glycation.
The concentrations of the α-oxoaldehydes increased in the incubations to a maximum value where the rate of α-oxoaldehyde formation equals the rate of α-oxoaldehyde removal ; the latter is expected to occur by reaction with N α -t-BOC-lysine to form AGEs and spontaneous degradation. In the glycation of HSA by glucose, α-oxoaldehydes may also be consumed by reaction with arginine residues to form hydroimidazolone derivatives [34] [35] [36] . This accounts for the lack of accumulation of glyoxal and methylglyoxal in the glucose glycation incubation with HSA. 3-DG, however, still accumulated but it has about 200-fold lower reactivity with arginine residues than glyoxal and methylglyoxal [37, 38] .
The initial rates of formation of the glyoxal, methylglyoxal and 3-DG by glucose glycation were dependent on phosphate buffer concentration and availability of trace metal ions. The exception was the initial increase in concentration of glyoxal and methylglyoxal with HSA but here only very low steady state concentrations of these α-oxoaldehydes were found. An initial activating deprotonation is implicated in the formation of all of α-Oxoaldehydes in glucose glycation the α-oxoaldehydes and phosphate dianion HPO % #− may fulfil this role. Phosphate buffer has been found previously to promote glucose glycation [39] . There are also trace redox active metal ions in phosphate buffer that promote oxidative steps involved in glyoxal formation [24] . This explains why glyoxal formation was particularly sensitive to the presence of DETAPAC. The formation of methylglyoxal and 3-DG, however, does not involve oxidation. Trace metal ion-phosphate complexes may facilitate activating deprotonation of the Schiff's base. A similar effect was observed previously [29] . In the presence of the DETAPAC, the initial rates of formation of glyoxal and 3-DG by glucose and N α -t-BOC-lysine were not significantly different from those of glucose degradation alone (Figures 1c and 2g) . In early glycation processes under anti-oxidative conditions, glucose degradation may be a significant source of glyoxal, methylglyoxal and 3-DG.
The fragmentation of the hexose moiety during α-oxoaldehyde formation forms other monosaccharides : erythrose and glyceraldehyde. Evidence of 3 and 4 carbon products was reported [40] . These also participate in oxidation and dehydration reactions forming α-oxoaldehydes [24] . This work has focused on glyoxal, methylglyoxal and 3-DG because of their importance in AGE formation. Ribose and other saccharides may also undergo similar fragmentation reactions forming glyoxal and methylglyoxal. The detection of glyoxal and methylglyoxal-derived hydroimidazolones in collagen glycated by ribose supports this [36] .
α-Oxoaldehyde formation from the degradation of fructosyl-lysine
The degradation of fructosyl-lysine also formed glyoxal, methylglyoxal and 3-DG. The rates of formation paralleled the rate of loss of fructosamine and were increased by phosphate buffer and trace metal ions, as found for the rate of fructosamine degradation [41] . Mechanistically, the formation of α-oxoaldehydes may occur via reversal of the Amadori rearrangement and formation from the Schiff's base [29, 32] . 3-DG is formed from fructosamine without reversal of the Amadori rearrangement in i o by phosphorylation to fructosamine-3-phosphate and spontaneous fragmentation of this to 3-DG [42] . Other α,β-dicarbonyl compounds are also formed from fructosamine without reversal of the Amadori rearrangement [12, 43] .
Consequences of α-oxoaldehyde formation in early glycation
Fragmentation of glucose in early glycation processes establishes many parallel glycation pathways that lead to the subsequent formation of AGEs. Analogous oxidation and dehydration reactions have been found in glycation by other hexoses and pentose derivatives. α-Oxoaldehydes react with lysine and arginine residues in proteins to form AGEs : glyoxal forms N ε -carboxymethyl-lysine, the glyoxal-derived bis(lysyl)imidazolium crosslink GOLD and hydroimidazolone ; methylglyoxal forms N ε -carboxyethyl-lysine, methylglyoxal-derived bis(lysyl)-imidazolium crosslink MOLD, hydroimidazolone and argpyrimidine ; and 3-DG forms pyrraline, the 3-DG-derived bis-(lysyl)imidazolium crosslink DOLD and hydroimidazolonereviewed in [14] . Glyoxal, methylglyoxal and 3-DG derived AGEs may be present in proteins glycated by glucose : we have recently detected N ε -carboxyethyl-lysine in albumin glycated by glucose [44] . Methylglyoxal-derived AGEs are common to proteins modified by glucose and by the authentic α-oxoaldehyde. Indeed, similar binding to AGE receptors has been found for these proteins [20] . The formation of α-oxoaldehydes from monosaccharides, Schiff's bases and fructosamines suggests that AGEs may be formed at all stages of glycation. The increased formation of α-oxoaldehydes in early glycation implicates relatively short-term excursions to hyperglycaemia, as occurs in impaired glucose tolerance, in the increased formation of α-oxoaldehydes and associated AGEs. There are, however, other important sources of these α-oxoaldehydes in i o : glyoxal is formed in lipid peroxidation ; methylglyoxal is formed by the fragmentation of triosephosphates, and the catabolism of ketone bodies and threonine ; and 3-DG is formed from fructose-3-phosphate. AGEs are risk markers and risk predictors of diabetic complications. A wealth of experimental evidence supports the hypothesis that AGEs formed from glyoxal, methylglyoxal and 3-DG have an aetiological role in the development of diabetic complications and other diseases [14, 45] . It is important, therefore, to characterize further the sources of these α-oxoaldehyde AGE precursors. Glyoxal, methylglyoxal and 3-DG can now be seen to play a part in all stages of glycation by glucose.
